scholarly journals Adverse events, resource use, and economic burden associated with mantle cell lymphoma: a real-world assessment of privately insured patients in the United States

2018 ◽  
Vol 60 (4) ◽  
pp. 955-963 ◽  
Author(s):  
Ravi K. Goyal ◽  
Saurabh P. Nagar ◽  
Shaum M. Kabadi ◽  
James A. Kaye ◽  
Brian Seal ◽  
...  
Keyword(s):  
United States ◽  
Adverse Events ◽  
Mantle Cell Lymphoma ◽  
Resource Use ◽  
Real World ◽  
Economic Burden ◽  
Cell Lymphoma ◽  
The United States ◽  
Mantle Cell ◽  
Insured Patients

scholarly journals Cost-effectiveness for KTE-X19 CAR T therapy for adult patients with relapsed/refractory mantle cell lymphoma in the United States

2021 ◽  
Vol 24 (1) ◽  
pp. 421-431
Author(s):  
Claire L. Simons ◽  
Daniel Malone ◽  
Michael Wang ◽  
Gregory A. Maglinte ◽  
Tim Inocencio ◽  
...  
Keyword(s):  
United States ◽  
Cost Effectiveness ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
The United States ◽  
Adult Patients ◽  
Car T ◽  
Mantle Cell

Incidence trends of mantle cell lymphoma in the United States between 1992 and 2004

Cancer ◽  
2008 ◽  
Vol 113 (4) ◽  
pp. 791-798 ◽  
Author(s):  
Yuhong Zhou ◽  
Haijun Wang ◽  
Wenjing Fang ◽  
Jorge E. Romaguer ◽  
Yanxia Zhang ◽  
...  
Keyword(s):  
United States ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
The United States ◽  
Incidence Trends ◽  
Mantle Cell

Survival trends in mantle cell lymphoma in the United States over 16 years 1992–2007

2012 ◽  
Vol 53 (8) ◽  
pp. 1488-1493 ◽  
Author(s):  
Rekha Chandran ◽  
Stuart K. Gardiner ◽  
Miklos Simon ◽  
Stephen E. Spurgeon
Keyword(s):  
United States ◽  
Mantle Cell Lymphoma ◽  
Cell Lymphoma ◽  
The United States ◽  
Mantle Cell
Sign in / Sign up

Export Citation Format

Share Document